SONN
NASDAQ
$1.26
Sonnet BioTherapeutics Holdings Inc (SONN)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$8.92M
Price Chart
Valuation
Market Cap$8.92M
Profitability
Total Revenue (TTM)$1M
Gross Profit (TTM)-$768K
EBITDA-$16M
EPS-$4.09
Growth & Risk
FCF 5Y CAGR-1.45%
Sharpe Ratio0.63